ACCEL INDEX


Saturday, November 21
ACCEL Search

Many 2001 or later ACCEL issues are available for $25 per issue. Call 1-800-253-4636 x694 or 202-375-6694 for availablity and place your order.
Search by Year Search by Keyword, Title, Interviewer or Interviewee
                     
Published Date Interviewee Interviewer Title
1999-01 Daniel Brunner, MD Cindy L. Grines, MD The BIP (Bezafibrate Infarction Prevention) Study
1999-01 Ralph J. Damiano, MD Lawrence I. Bonchek, MD Robotically Assisted Endoscopic Coronary Artery Bypass Grafting: An Acute Large Animal Trial
1999-01 Valentin Fuster, MD, PhD Sylvan Lee Weinberg, MD How Can ACC and AHA Work Together in the Future?
1999-01 Antonio M. Gotto, Jr., MD Killian C. Robinson, MD The AFCAPS Study and State-of-the-Art in Triglycerides
1999-01 John Guyton, MD Killian C. Robinson, MD Time to Reconsider Niacin?
1999-01 Igor Holme, PhD Sylvan Lee Weinberg, MD Treating Hypertensive Patients With Statins
1999-01 David R. Holmes, Jr., MD Sylvan Lee Weinberg, MD Provisional Versus Routine Stenting? - Routine
1999-01 A.G. Jardine, MD William L. Winters, Jr., MD Treating Transplanted Patients With Statins
1999-01 Spencer B. King, III, MD Sylvan Lee Weinberg, MD Provisional Versus Routine Stenting? - Provisional
1999-01 Dan Kromhout, MD Richard P. Lewis, MD On the Waves of the Seven Countries Study
1999-01 Peter Libby, MD George A. Beller, MD Stabilization of the Vulnerable Atherosclerotic Plaque
1999-01 Jane A. McCrohon, MD Phillip J. Harris, MB, BS, PhD Gender Specific Effects of Sex Steroids on Foam Cell Formation
1999-01 Melvin M. Scheinman, MD Eric L. Michelson, MD New and Standard Therapy for the Long QT Syndrome
1999-01 Peter J. Schwartz, MD S. Ben Freedman, MBBS, PhD Update in Long QT Syndrome
1999-01 Frank W. Sellke, MD Adolph M. Hutter, Jr., MD Surgical Angiogenesis With bFGF or VEGF
1999-01 R. John Simes, MD Sylvan Lee Weinberg, MD Clinical and Economic Outcomes From the Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID) Study
1999-01 Craig R. Smith, MD Richard J. Shemin, MD Surgical Angiogenesis with TMR
1999-01 G. Michael Vincent, MD Michael J. Davies, MD Congenital Long QT Syndromes: Clinical Implications of Recent Advances
1999-01 Sylvan L. Weinberg, MD Editorial Type II Diabetes, Coronary Artery Disease, and Hypoglycemic Agents Revisited
1999-01 Harvey D. White, MD, DSc Sylvan Lee Weinberg, MD Reduction of Stroke in the LIPID Trial
1999-01 Wojciech Zareba, MD, PhD James A. Manning, MD The Effect of Age and Gender on Cardiac Events in Genotyped LQTS Families
1999-02 Romualdo Belardinelli, MD Michael H. Sketch, Sr., MD Beneficial Effects of Moderate Exercise Training After Coronary Angioplasty: A Randomized Prospective Controlled Study
1999-02 Peng-Sheng Chen, MD Ben D. McCallister, MD How Does the Heart Defibrillate?
1999-02 James H. Chesebro, MD Sylvan Lee Weinberg, MD Antithrombotic Therapy in Acute Coronary Syndromes
1999-02 Nicolas Danchin, MD Sylvan Lee Weinberg, MD Revascularization in Multivessel Disease -- Angioplasty or Thrombolysis?
1999-02 Pim J. de Feyter, MD Adolph M. Hutter, Jr., MD Angiographic and Intravascular Ultrasound Evidence for Regression or Retardation of Progression of Coronary Lesions
1999-02 Andrew E. Epstein, MD Gunter Breithardt, MD Candidates for Cardioversion from Atrial Fibrillation
1999-02 Rodney H. Falk, MD Adolph M. Hutter, Jr., MD Calcium Channel Blockers for the Maintenance of Sinus Rhythm in Patients Converted From Sustained Atrial Fibrillation
1999-02 David P. Faxon, MD Arthur Garson, Jr., MD, MPH In-Stent Restenosis: A Problem Without a Solution?
1999-02 Bernard J. Gersh, MB, ChB, DPhil David O. Williams, MD Management of Patients With Atrial Fibrillation
1999-02 Cindy L. Grines, MD David O. Williams, MD Stent PAMI: Primary Endpoint Results of a Multicenter Randomized Trial of Heparin-Coated Stenting vs. Primary PTCA for AMI
1999-02 Annette L. Gullov Bertram Pitt, MD Fixed Mini-Dose Warfarin and Aspirin, Each Alone or in Combination, Versus Adjusted-Dose Warfarin for Stroke Prevention in Atrial Fibrillation: The AFASAK 2 Study
1999-02 Phillip J. Harris, MB, BS, PhD Sylvan Lee Weinberg, MD Cardiac Society of Australia and New Zealand and Medicine in Australia
1999-02 Charles H. Hennekens, MD, DrPH Michael H. Sketch, Jr., MD Is Aspirin for Everyone?
1999-02 Dean J. Kereiakes, MD Steven E. Nissen, MD Use of GpIIb/IIIa Antagonists with Balloon Angioplasty
1999-02 Mark McGuire, MD Phillip J. Harris, MB, BS, PhD Implantable Defibrillation: First Line Treatment for Ventricular Arrhythmias?
1999-02 Francis D. Murgatroyd, BM, BCh Sylvan Lee Weinberg, MD Quality of Life of Patients With Atrial Fibrillation
1999-02 Erik Magnus Ohman, MD Michael H. Sketch, Sr., MD GUSTO-IV Pilot (SPEED) Trial
1999-02 Nadir Saoudi, MD Richard P. Lewis, MD Is Idiopathic Atrial Fibrilation Always Benign?
1999-02 Alec S. Vahanian, MD Richard P. Lewis, MD Angioplasty or Medical Treatment
1999-02 Jitu Vohra Sylvan Lee Weinberg, MD What Are the Outcomes With Current Implantable Cardioverter Defibrillators?
1999-02 Sylvan L. Weinberg, MD Editorial Evidence Based Medicine: A Clinical Critique
1999-03 Peter B. Berger, MD William L. Winters, Jr., MD Clopidogrel Versus Ticlopidine for Coronary Stents
1999-03 Carolyn L. Donovan, MD Michael H. Sketch, Sr., MD Transmyocardial Laser Revascularization
1999-03 Eugene A. Grossi, MD Lawrence I. Bonchek, MD Impact of Minimally Invasive Valvular Heart Surgery: A Case Controlled Study
1999-03 Alain Hagege, MD Nicolas Danchin, MD Cellular Cardioplasty: Hope for Myocardial Infarction
1999-03 Timothy D. Henry, MD Michael H. Sketch, Sr., MD Double Blind, Placebo-Controlled Trial of Recombinant Human Vascular Endothelial Growth Factor: VEGF in Ischemia for Vascular Angiogenesis (VIVA) Trial
1999-03 David R. Holmes, Jr., MD Sylvan Lee Weinberg, MD Minimally Invasive CABG for One and Two Vessel Disease
1999-03 G. Chad Hughes, MD Michael H. Sketch, Jr., MD Early Postoperative Changes in Regional Systolic and Diastolic Left Ventricular Function Following Transmyocardial Laser Revascularization (TMR) With Holmium: YAG and CO2 Lasers
1999-03 Joseph Lindsay, Jr., MD Phillip J. Harris, MB, BS, PhD Angioplasty Outcomes: Does Operator Volume Matter
1999-03 Michael J. Mack, MD Lawrence I. Bonchek, MD Minimally Invasive CABG for One and Two Vessel Disease
1999-03 Lynda L. Mickleborough, MD Michael H. Sketch, Sr., MD Arrested Heart Surgery vs Beating Heart Surgery
1999-03 Gilles Montalescot, MD, PhD James H. Chesebro, MD The ADMIRAL Study: Abciximab With PTCA and Stent in AMI
1999-03 Jeffrey Moses, MD Michael H. Sketch, Jr., MD The Safety and Effectiveness of the Combination of Clopidogrel and Aspirin Versus Ticlid and Aspirin After Coronary Stent Implantation
1999-03 Stephen N. Oesterle, MD Adolph M. Hutter, Jr., MD Randomized Comparison of PMR Versus Medical Therapy: Six-Month Outcome of the PACIFIC Trial.
1999-03 William W. O'Neill, MD Valentin Fuster, MD, PhD The Evaluation of Xemilofiban in Controlling Thrombotic Events (EXCITE) Trial: 30-Day and Six-Month Results
1999-03 Robert Roberts, MD Robert Wayne Alexander, MD, PhD What is the Human Genome Project and What Will Happen When it is Completed?
1999-03 Renu Virmani, MD Sylvan Lee Weinberg, MD Pathology of Angiogenesis
1999-03 David A. Vorchheimer, MD James H. Chesebro, MD Safety and Efficacy of Eptifibatide Therapy in Patients With Previous Stroke or Transient Ischemic Attack
1999-03 Lars Wallentin, MD, PhD J. Ward Kennedy, MD Fast Revascularization During Instability in Coronary Artery Disease (FRISC II): An Early Invasive Versus Early Noninvasive Strategy in Unstable Coronary Artery Disease
1999-03 Sylvan L. Weinberg, MD Editorial Myocardial Revascularization: A Time of Change and Controversy
1999-03 Harvey D. White, DSc Richard P. Lewis, MD Unstable Angina: When to Intervene?
1999-04 Loic Capron, MD C. Richard Conti, MD Is Atherosclerosis an Infectious Disease?
1999-04 Blase Carabello, MD Lawrence I. Bonchek, MD Surgical Therapy is Recommended for Asymptomatic Patients With Severe Aortic Valve Stenosis - Antagonist's View
1999-04 E. Gordon DePuey, MD William L. Winters, Jr., MD Nuclear Techniques for Reducing Hospital Costs and Length of Stay: Simultaneous Evaluation of Perfusion and Function
1999-04 John Downs, MD Michael H. Sketch, Sr., MD Air Force/Texas Coronary Atherosclerosis Prevention Study: Primary Prevention of Coronary Heart Disease in Women
1999-04 Stephen E. Epstein, MD Eric L. Michelson, MD Role of Infection in Coronary Disease
1999-04 Anne G. Farrell, MD Arthur Garson, Jr., MD, MPH Event Free Survival of Pediatric Patient With Aortic Regurgitation
1999-04 Christine Gohlke-Barwolf, MD Richard P. Lewis, MD Aortic Stenosis
1999-04 Rory Hachamovitch, MD Steven E. Nissen, MD Nuclear Techniques for Reducing Hospital Costs and Length of Stay: Gatekeeper to the Cath Lab
1999-04 Stephen E. Humphries, PhD S. Ben Freedman, MBBS, PhD Genes Involved in Inflammation, Platelet Response and Endothelial Dysfunction
1999-04 Mark S. Link, MD Adolph M. Hutter, Jr., MD Sudden Death from Baseballs
1999-04 Barry J. Maron, MD James A. Manning, MD Commotiocordis: A Cause of Sudden Death in the Athlete
1999-04 Attilio Maseri, MD Sylvan Lee Weinberg, MD Role of Inflammation and Coronary Artery Disease
1999-04 Catherine M. Otto, MD Robert O. Bonow, MD Low Gradient in Aortic Stenosis
1999-04 Shahbudin H. Rahimtoola, MD Lawrence I. Bonchek, MD Surgical Therapy is Recommended for Asymptomatic Patients with Severe Aortic Valve Stenosis - Protagonist's View
1999-04 Paul M. Ridker, MD, MPH Killian C. Robinson, MD C-Reactive Protein and the Risk of Future Cardiovascular Events Among Apparently Health Women
1999-04 Prediman K. Shah, MD Bernard J. Gersh, MB, ChB, Dphil Inflammation and Chlamydia in CAD
1999-04 Martin G. St. John Sutton, MBBS, FACC W. Bruce Fye, MD, MA Role of Echo in MI: Follow-Up
1999-04 William Stanford, MD Bruce H. Brundage, MD New Approaches to Imaging: Pulmonary Embolism
1999-04 Sylvan L. Weinberg, MD Editorial Inflammation, Infection and Acute Coronary Disease
1999-04 Nanette Kass Wenger, MD Killian C. Robinson, MD Clinical Trials in Women
1999-05 Gerard P. Aurigemma, MD Richard P. Lewis, MD Mechanisms and Impact of Left Ventricular Hypertrophy and Remodeling and Hypertension
1999-05 John G. F. Cleland, MD William L. Winters, Jr., MD What's Next in the Treatment of Heart Failure
1999-05 Gilles D. Dreyfus, MD C. Richard Conti, MD The Batista Procedure in Dilated Cardiomyopathy
1999-05 Arthur M. Feldman, MD, PhD Douglas P. Zipes, MD New Targets for Treatment of Chronic Heart Failure
1999-05 Bernard J. Gersh, MB, CHB, DPhil Peter Sleight, MD Atrial Fibrillation and Congestive Heart Failure: The Chicken or the Egg?
1999-05 Akira T. Kawaguchi, MD, PhD Anthony N. DeMaria, MD Partial Left Ventriculectomy for Patients with Ischemic Cardiomyopathy
1999-05 Thomas F. Luscher, MD Robert Wayne Alexander, MD, PhD Endothelial Function in Coronary Artery Disease and Hypertension
1999-05 Douglas L. Mann, MD Phillip J. Harris, MB, BS, PhD Cytokines as New Targets for Treatment of Chronic Heart Failure
1999-05 Attilio Maseri, MD S. Ben Freedman, MBBS, PhD Syndrome X
1999-05 Charles R. McKay, MD James S. Forrester, MD Physician Credentialing
1999-05 Andrea Mortara, MD Cindy L. Grines, MD Instability of Respiratory Control Systems in Chronic Heart Failure, Role of Oxygen Transport on Chemoreceptor Hypersensitivity
1999-05 Marvin Moser, MD James S. Forrester, MD Pharmacologic Therapy of Hypertension: New Studies, New Trials -- Will More Therapeutic Choices Improve Outcomes?
1999-05 Issam Moussa, MD Sylvan Lee Weinberg, MD Do Patients With Diabetes Mellitus Have an Increased Risk of Restnosis After Coronary Stenting? A Matched Comparison to Patients Without Diabetes
1999-05 Christopher M. O'Connor, MD, FACC Michael H. Sketch, Jr., MD Cardiac Rehab is Associated with Improved Survival in CHF Patients
1999-05 Bertram Pitt, MD Sylvan Lee Weinberg, MD The Randomized Aldactone Evaluation (RALES) Study
1999-05 Lars E. Ryden, MD, FESC James S. Forrester, MD Diabetes and the Heart
1999-05 Randall C. Starling, MD, MPH C. Richard Conti, MD Left Ventricular Volume Reduction Surgery
1999-05 Karl B. Swedberg, MD, PhD Adolph M. Hutter, Jr., MD Beta-Blocker Treatment of Heart Failure in Daily Practice
1999-05 Sylvan L. Weinberg, MD Editorial Guidelines and Intuition: Counterpoints in the Art of Medicine
1999-06 A. John Camm, MD C. Richard Conti, MD Poisonous Pro-arrhythmic Pills
1999-06 George Dangas, MD Richard O. Russell, Jr., MD Is Carotid Stenting the Preferred Treatment in High-Risk Surgical Carotid Endarterectomy Patients?
1999-06 John Philip Di Marco, MD, PhD Paul C. Gillette, MD Advanced Ablation Techniques
1999-06 Ronald Elkins, MD Anthony N. DeMaria, MD The ROSS Operation: Indications and Midterm Results
1999-06 Kenneth A. Ellenbogen, MD Eric L. Michelson, MD Interpretation of Pacemaker ECGs
1999-06 J. Simon R. Gibbs, MD, MRCP C. Richard Conti, MD Prostaglandin Treatment of Pulmonary Hypertension
1999-06 Timothy Higenbottam, MD, MA, BSC Sylvan Lee Weinberg, MD Should We Treat Pulmonary Disease?
1999-06 David R. Holmes, Jr., MD David O. Williams, MD Late Breaking Trials in Interventional Cardiology from ACC '99
1999-06 Vallerie McLaughlin, MD Bruce H. Brundage, MD Overcoming Tolerance to Prostacyclin in Primary Pulmonary Hypertension
1999-06 Ulrich Sigwart, MD Michael H. Sketch, Jr., MD Non-Surgical Myocardial Reduction in Hypotrophic Cardiomyopathy
1999-06 David Jan Skorton, MD Jane Somerville, MD Late Results for Tetralogy of Fallot
1999-06 William H. Spencer, III, MD Editorial Non-Surgical Therapy for Hypertrophic Obstructive Cardiomyopathy: One-Year Follow-Up
1999-06 Melle D. Talsma, MD Jacqueline A. Noonan, MD Long-Term Results in Ventricular Septal Defects and a Moderate Left to Right Shunt, With and Without Operation
1999-06 Cynthia M. Tracy, MD Francis J. Klocke, MD Is Catheter Ablation Primary Therapy for SVT?
1999-06 Ron Waksman, MD Nicolas Danchin, MD Intracoronary Beta Radiation Therapy for In Stent Restenosis: Preliminary Report From a Single Center Clinical Study
1999-06 Edward P. Walsh, MD Arthur Garson, Jr., MD, MPH Management of the Infant with SVT
1999-06 David D. Waters, MD Sidney C. Smith, Jr., MD Aggressive Lipid Lowering Versus Coronary Angioplasty in Patients With Inducible Myocardial Ischemia: An AVERT Substudy
1999-06 Sylvan L. Weinberg, MD Editorial The AMA and US Congress: Responding to the Tyranny of the HMO - Insurance Complex
1999-06 James L. Wilkinson, MB, ChB Jacqueline A. Noonan, MD Amplatzer Occluder in Closing ASDs
1999-07 Andrew E. Arai, MD Charles A. Boucher, MD Cardiac Magnetic Resonance Imaging - Update 1999
1999-07 Michael J. Davies, MD Sylvan Lee Weinberg, MD Clinical Significance of Plaque Rupture
1999-07 Vasken Dilsizian, MD George A. Beller, MD SPECT Myocardial Perfusion Imaging
1999-07 Eric L. Eisenstein, DBA Barry L. Zaret, MD The Cost-Effectiveness of an Aggressive Diagnostic Strategy with SPECT Myocardial Perfusion Imaging and Early Exercise Stress Testing in ER Patients With Nondiagnostic Pain Syndromes
1999-07 James S. Forrester, MD Ben D. McCallister, MD The Cell Biology and Clinical Relevance of Unstable Lesions
1999-07 Jacques J. G. Genest, MD, CM Killian C. Robinson, MD Treatment Strategies for Homocysteinemia: Rationale and Regimens
1999-07 Raymond J. Gibbons, MD Robert O. Bonow, MD Worsening Clinical Status During Follow-Up Predicts Future Events Better Than Serial Exercise Thallium-201 Testing and/or Radioisotope Imaging
1999-07 Henry Ginsberg, MD James S. Forrester, MD Are High Triglycerides Important?
1999-07 Charles A. Herzog, MD Lawrence I. Bonchek, MD Survival of Dialysis Patients After CABG, PTCA and Coronary Stenting
1999-07 Judith S. Hochman, MD R. Joe Noble, MD The SHOCK Trial: Emergency Revascularization for Cardiogenic Shock
1999-07 Dudley J. Pennell, MD Michael H. Sketch, Sr., MD Nuclear Cardiology for the Heart Failure Specialist
1999-07 Anthony F. Rickards, MBBS Sylvan Lee Weinberg, MD Creating a Database for Quality Assurance: The British National Health Service Approach
1999-07 Frank M. Sacks, MD Killian C. Robinson, MD How Far Should LDL Cholesterol Be Lowered in Health and Coronary Artery Disease Subjects?
1999-07 William H. Spencer, III, MD C. Richard Conti, MD Therapy for Hypertrophic Obstructive Cardiomyopathy: One-Year Follow-Up
1999-07 H. Robert Superko, MD Killian C. Robinson, MD Significance of Lp(a) and LDL Particle Size
1999-07 Koon K. Teo, MB, PhD David R. Holmes, Jr., MD The Simvastatin/Enalapril Coronary Atherosclerosis (SCAT) Trial
1999-07 Karl T. Weber, MD James S. Forrester, MD Importance of Extracellular Matrix
1999-07 Sylvan L. Weinberg, MD Editorial Lipid Modification Toward the Control of Atherothrombosis
1999-07 Richard D. Weisel, MD Phillip J. Harris, MB, BS, PhD Feasibility of Myocyte Transplantation
1999-07 Kim Allan Williams, MD Adolph M. Hutter, Jr., MD Prediction of Outcome in Patients With CAD using RNA and SPECT
1999-08 Raefel Balcon Richard P. Lewis, MD The London Heart Hospital
1999-08 Marc Cohen, MD C. Richard Conti, MD Low Molecular Weight Heparins in Unstable Angina
1999-08 Michael D. Ezekowitz, MB, ChB Bruce H. Brundage, MD Warfarin and Aspirin Combination Therapy
1999-08 William H. Gaasch, MD Peter Sleight, MD Incidence and Diagnosis of Systolic Dysfunction
1999-08 Welton M. Gersony, MD Jane Somerville, MD When to Perform Aortic Valve Replacement in the Pediatric Patient
1999-08 Christa Gohlke-Barwolf, MD James S. Forrester, MD Aortic Stenosis in the Elderly
1999-08 Christian W. Hamm, MD Michael J. Davies, MD Troponin T Predicts the Benefit of Abciximab in Patients with Unstable Angina in the CAPTURE Study
1999-08 Ake Hjalmarson, MD Jeffrey M. Isner, MD Metoprolol CR/XL Randomized Intervention Trial in Heart Failure (MERIT-HF)
1999-08 Samuel Kaplan, MD Jacqueline A. Noonan, MD Common Congenital Heart Disease in Adults
1999-08 Anne M. Keogh, MD Steven E. Nissen, MD Should Intravenous Inotropic Drugs Be Given Intermittently?
1999-08 Spencer B. King, III Sylvan Lee Weinberg, MD ACC 50th Anniversary: Historical Perspectives and Future Directions
1999-08 Marvin A. Konstam, MD Killian C. Robinson, MD Pharmacologic Interventions in Heart Failure
1999-08 Gervasio A. Lamas, MD Antonio Bayes De Luna, MD Management of Post-Infarction Ventricular Dysfunction
1999-08 William W. Parmley, MD Michael H. Sketch, Sr., MD Gender Considerations in Diagnosis and Treatment of Heart Failure
1999-08 Shahbudin H. Rahimtoola, MD Richard O. Russell, Jr., MD The Patient With Prosthetic Heart Valves
1999-08 David J. Sahn, MD Paul C. Gillette, MD Telemedicine Strategies for Pediatric Cardiology
1999-08 Kathryn A. Taubert, PhD Robert O. Bonow, MD Antibiotic Prophylaxis
1999-08 Frans J. Van de Werf, MD, FESC W. Douglas Weaver, MD Assessment of the Safety and Efficacy of a New Thrombolytic: TNK-tPA (ASSENT-2)
1999-08 William S. Weintraub, MD Bernard J. Gersh, MB, ChB, Dphil Ten Year Trends in the Management of Valvular Heart Disease
1999-09 Thomas Aversano, MD Peter Sleight, MD Primary PTCA for MI: The Community Hospital Experience
1999-09 Yochai Birnbaum, MD J. Ward Kennedy, MD Ventricular Septal Defect in Anterior Acute Myocardial Infarction in the Thrombolytic Era: Electrocardiographic and Clinical Variables Associated With Increased Risk
1999-09 Robert O. Bonow, MD George A. Beller, MD Immediate Angiography and Intervention is the Best Approach in Acute Myocardial Infarctioin - Antagonist View
1999-09 Bruce R. Brodie, MD Michael H. Sketch, Jr., MD Evolution of Primary PTCA for Acute Myocardial Infarction: Changes in 30-Day Mortality, Reinfarction, and Urgent Target Vessel Revascularization From 1984-1997
1999-09 Alfred E. Buxton, MD W. Douglas Weaver, MD Multicenter Unsustained Tachycardia (MUSTT) Trial
1999-09 Antonio Colombo, MD Cindy L. Grines, MD A Matched Comparison Between Spot Stenting and Traditional Stenting for the Treatment of Long Lesions
1999-09 Charles J. Davidson, MD Michael H. Sketch, Jr., MD The COURT Trial (A Randomized Trial of Contrast Media Utilization in High Risk PTCA)
1999-09 A. Michael Lincoff, MD Ben D. McCallister, MD What is the Role of Abciximab and Epitifibide in AMI?
1999-09 William J. Lyon Sylvan Lee Weinberg, MD Elevated Preoperative Troponin T Predicts Adverse Outcomes After Cardiac Surgery
1999-09 Gary S. Mintz, MD Ben D. McCallister, MD Relationship Between Baseline (Pre-Intervention) Remodeling and Arterial Responses in the First Month Post-Intervention: An Intravascular Ultrasound Analysis From the SURE Trial
1999-09 Karl-Ludwig Neuhaus, MD Sylvan Lee Weinberg, MD Noninvasive Assessment of Infarct Related Artery Patency After Thrombolysis for Acute Myocardial Infarction by ST Resolution: Results of the HIT-4 Angiographic Substudy
1999-09 Flavio Ribichini, MD Sylvan Lee Weinberg, MD Immediate Angiography and Intervention is the Best Approach in Acute Myocardial Infarctioin - Protagonist View
1999-09 Matthew T. Roe, MD S. Ben Freedman, MBBS, PhD Three-Fold Risk of Death with CPK Rise After PTCA
1999-09 Maarten L. Simoons, MD C. Richard Conti, MD Overview of the Promise of the Platelet Receptor GPIIb/IIIa Antagonists as an Adjunct to Thrombolytic Drugs
1999-09 Peter Sleight, MD Sylvan Lee Weinberg, MD Implications of HOPE for Cardiovascular Therapy
1999-09 William G. Stevenson, MD Richard P. Lewis, MD Catheter Ablation of Ventricular Tachycardia Following Mycoardial Infarction
1999-09 Daniel B. Stryer, MD Steven E. Nissen, MD A View of the Bridge: The Effectiveness of Interventions to Improve Cardiovascular Care
1999-09 Mark Charles Thel, MD Michael H. Sketch, Jr., MD Cardiopulmonary Resuscitation for In-Hospital Cardiac Arrest: In the Modern Era Have We Made Any Progress?
1999-09 W. Douglas Weaver, MD Sidney C. Smith, Jr., MD Optimal Angioplasty Versus Primary Stenting (OPUS) Trial
1999-09 Sylvan L. Weinberg, MD Editorial Managing the Excesses of Managed Care: The Courts or the Congress?
1999-10 Keith B. Allen, MD Lawrence I. Bonchek, MD Randomized Trial of TMLR & CABG vs. CABG Only
1999-10 Ezra A. Amsterdam, MD Sylvan Lee Weinberg, MD The Immediate Treadmill Test in Emergency Room Patients with Chest Pain: Significance of a Negative Test
1999-10 James Crowley, MD Sylvan Lee Weinberg, MD Efficacy of Primary Stenting for Atherosclerotic Renal Artery Stenosis in Patients with Hypertension and Chronic Renal Failure
1999-10 Murray D. Esler, MB, PhD Phillip J. Harris, MB, BS, PhD Neural Mechanisma in Human Obesity Related Hypertension
1999-10 Michael E. Farkouh, MD James H. Chesebro, MD Chest Pain Evaluation in the Emergency Room
1999-10 Sean Fleming, MD Richard P. Lewis, MD Is Mandatory Exercise Stress Testing Indicated for Patients with Resting Chest Pain and Serum Cardiac Troponin I of Less Than 0.03 NG/ML?
1999-10 Mihai Gheorghiade, MD Francis J. Klocke, MD Is There Still a Role for Digitalis?
1999-10 Timothy S. Hall, MD Lawrence I. Bonchek, MD Are Acute Outcomes Worse for "All Arterial" Coronary Bypass Surgery? A Comparison Based on the Number of Arterial Conduits Used
1999-10 John H. Horgan, MD Sylvan Lee Weinberg, MD The Irish Cardiac Society-Then and Now
1999-10 Hamid Ikram Phillip J. Harris, MB, BS, PhD Contemporary Vare of the Failing Heart: An Antipodean Perspective
1999-10 Rod Jackson Richard P. Lewis, MD A Summation of Errors-The Epidemiological Use and Misuse of Blood Pressure Measurements
1999-10 J. Mark Jones, MD Richard P. Lewis, MD Beating Heart Surgery-Is Concern Over Graft Patency Justified?
1999-10 Harold L. Lazar, MD Adolph M. Hutter, Jr., MD Beneficial effects of angiotensin converting enzyme-inhibition during surgical revascularization of acutely ischaemic myocardium.
1999-10 Herbert J. Levine, MD William L. Winters, Jr., MD ACC 50th Anniversary: Historical Perspectives on Heart Failure
1999-10 Gary Nichols, MD Richard P. Lewis, MD Hypertension-the Skeleton in the Heart Failure Closet
1999-10 Eoin O'Brien Sylvan Lee Weinberg, MD When is High Blood Pressure Hypertension?
1999-10 Dudley J. Pennell, MD Richard P. Lewis, MD Measurement of Ventricular Remodelling in Man
1999-10 Gary S. Roubin, MD, PhD Nicolas Danchin, MD Four-Year Experience With Carotid Stenting
1999-10 Norman D. Sharpe, MD Richard P. Lewis, MD Left Ventricular Remodelling in Heart Failure: A New Target for Treatment
1999-10 Mahen P. Varma, MD Richard P. Lewis, MD Pre-Hospital Thrombolysis in a Rural Area: Five Year Survival Data
1999-10 Sylvan L. Weinberg, MD Editorial 50th Anniversary of the Irish Cardiac Society - Remebering the "Dublin School"
1999-11 Tracy Q. Callister, MD Peter Sleight, MD How Should We Use Coronary Artery Calcium Scores to Predict Events?
1999-11 Jay N. Cohn, MD Sylvan Lee Weinberg, MD The MOXCON Trial (Moxonidine Congestive Heart Failure Trial)
1999-11 Rory Collins, MBBS James H. Chesebro, MD Epidemiological Overview
1999-11 D.M. Colquhoun, MD Sylvan Lee Weinberg, MD Meta-Analysis of 15 Cholesterol Lowering Trials: Are Treatment Targets Correct?
1999-11 John E. Deanfield, MBBChir C. Richard Conti, MD Physical Exercise and Endothelial Function
1999-11 N.A. Mark Estes, III, MD Adolph M. Hutter, Jr., MD Arrythmias and Participation in Athletics
1999-11 Valentin Fuster, MD, PhD Sylvan Lee Weinberg, MD Use of Magnetic Resonance To Study In Vivo Atherosclerosis in Humans
1999-11 Terry Kavanagh, MD Richard P. Lewis, MD Vigorous vs. Non-Vigorous Exercise in Cardiac Rehabilitation and Secondary Prevention
1999-11 Paul Keelan, MD Sylvan Lee Weinberg, MD Extent of Coronary Calcification on Electron Beam CT Scan Is An Excellent Predictor of Future Cardiac Events in Patients Referred for Coronary Angiography
1999-11 Daniel Levy, MD Eric L. Michelson, MD 50 Years of Research Achievements by the Framingham Heart Study
1999-11 Barry J. Maron, MD Richard P. Lewis, MD Participation in Athletics: A Cardiologist's View
1999-11 Malcolm J. Metcalfe, MD, FRCP Michael H. Sketch, Sr., MD What Can Nuclear Cardiology Do For Me? Overview of Applications
1999-11 Bertram Pitt, MD Sylvan Lee Weinberg, MD ELITE II: Angiotensin II Receptor Blocker vs. ACE Inhibitor in Severe Heart Failure
1999-11 Paul M. Ridker, MD, MPH Sidney C. Smith, Jr., MD Long Term Effects of Provostatin on C Reactive Protein
1999-11 Rod Taylor, MSc, PhD Sylvan Lee Weinberg, MD Cardiac Rehabilitation: Is Our Evidence Good Enough for the Millenium?
1999-11 Andrew Tonkin, MD Adolph M. Hutter, Jr., MD Results of Lipid Study: Care of the Post-Myocardial Infarction and Unstable Angina Patient
1999-11 Eric J. Topol, MD Nicolas Danchin, MD The SYMPHONHY-1 Study (Sibrafiban versus aspirin to Yield Maximum Protection from ischaemic Heart events post acute coronary syndromes)
1999-11 S. Richard Underwood, MD, FRCP, FRCR, FESC Sylvan Lee Weinberg, MD Can The Detection of Coronary Calcium Influence Diagnosis or Management?
1999-11 Carl J. Vaughan, MD Sylvan Lee Weinberg, MD Pleiotropic Actions of Statins in the Secondary Prevention of Coronary Artery Disease
1999-11 Sylvan L. Weinberg, MD Editorial On the Registration of Clinical Trials and the Question of Publication Bias for Negative Results
1999-12 Keith D. Aaronson, MD James H. Chesebro, MD How To Evaluate a Patient for Heart Transplantation
1999-12 Stefan D. Anker, PhD Adolph M. Hutter, Jr., MD Tumor Necrosis Factor-Alpha, Cachexia and Peripheral Muscle Function
1999-12 George A. Beller, MD Sylvan Lee Weinberg, MD Stress Imaging Techniques Should Be Recommended for Risk Stratification in Patients with Normal Resting Electrocardiograms Who Are Able to Exercise -- Protagonist View
1999-12 David S. Celermajer, MB, PhD S. Ben Freedman, MBBS, PhD Molecular Biology of the Vascular Wall and Angiogenesis
1999-12 Gerald F. Fletcher, MD James A. Manning, MD Obesity: US and the World
1999-12 Raymond J. Gibbons, MD Sylvan Lee Weinberg, MD Stress Imaging Techniques Should Be Recommended for Risk Stratification in Patients with Normal Resting Electrocardiograms Who Are Able to Exercise -- Antagonist View
1999-12 Sidney Goldstein, MD W. Bruce Fye, MD, MA Metoprolol CR/XL Randomized Interventional Trial in Congestive Heart Failure (MERIT)
1999-12 Jeffrey M. Isner, MD S. Ben Freedman, MBBS, PhD Therapeutic Angiogenesis in the Periphery
1999-12 W.R. Jamieson, MD Spencer B. King III, MD Bioprosthesis: Its Present Use and Future Trends
1999-12 Niall T. Mulvihill, MB, MRCPI Richard P. Lewis, MD Enhanced Endothelial Activation in Diabetic Patients with Acute Coronary Syndromes
1999-12 Bertram Pitt, MD C. Richard Conti, MD Aldosterone Antagonism-New Hope in Heart Failure
1999-12 Killian Robinson, MD C. Richard Conti, MD Folic Acid, Vitamin B6 and Vascular Diseases
1999-12 Lars E. Ryden, MD, FESC Sylvan Lee Weinberg, MD Coronary Artery Disease and Diabetes
1999-12 Oz M. Shapira, MD Lawrence I. Bonchek, MD Improved Clinical Outcomes With Coronary Endarterectomy in Patients Undergoing CABG
1999-12 Karl B. Swedberg, MD W. Douglas Weaver, MD Design of Future Trials to Address Questions of Polypharmacology
1999-12 L. Van-Thomas Crisco, MD Mervyn S. Gotsman, MD Twenty Year Outcome of CABG
1999-12 Robert A. Vogel, MD Steven E. Nissen, MD Endothelial Dysfunction: Do Vitamins Correct It?
1999-12 Sylvan L. Weinberg, MD Editorial On Time to Heal : Observations and a Review
1999-12 James T. Willerson, MD C. Richard Conti, MD Gene Transfection to Prevent Thrombosis to Injured Vessels
Page last updated Saturday, November 21, 2009 Email ACC